ArticleNPJ vaccines2022

Full efficacy and long-term immunogenicity induced by the SARS-CoV-2 vaccine candidate MVA-CoV2-S in mice.

Adrián Lázaro-Frías et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.